Nevertheless, we observed a significant difference in VpC-Msh2-TgfβRII tumor grade and serosal invasion pathology compared to tumors that arose in VpC-Msh2 mice (P ≤ 0.05; Figure 3B and 3C; Supplementary Table 2 and 3). The gene discussed is MSH2; the disease is neoplasm.